Ming-Chung Chou1, Jei-Yuan Li2, and Ping-Hong Lai3
1Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan, 2Department of Neurology, E-Da Hospital, Kaohsiung, Taiwan, 3Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Synopsis
This study performed a voxel-based
morphometry to investigate global gray matter changes in patients with acute CO
intoxication. The results show significantly decreased gray matter volumes mostly
in the pain-matrix regions, and significantly increased gray matter volumes in
the periaqueductal gray (pain-modulating center). In the pain-matrix regions, the
GM volumes were significantly negatively correlated with duration of coma,
suggesting that longer duration of coma may lead to more headache symptoms in
patients with acute CO intoxication.
Introduction
Carbon monoxide (CO)
intoxication has been demonstrated to cause gray matter (GM) changes and
headache symptom in CO patients. Headache is the most common neurological symptom
in CO patients even with low exposure level, and the pathophysiology of headache
might be characterized as an abnormality in the pain-modulating network1,2. A
previous study demonstrated that voxel-based morphometry (VBM) is capable of
detecting GM changes in the pain-matrix network of the brain in migraineurs3,
but the headache-associated GM changes are not well understood. The purpose of
this study was to perform a VBM analysis to investigate GM changes of the
pain-matrix network in patients with acute CO intoxication. Methods:
This study was
approved by the local institutional review board, and all subjects provided written
informed consent before participating in this study. We enrolled 24 patients
with acute CO intoxication (≤ 1 month) and 20 age- and gender- matched healthy
controls. MRI was performed on a 1.5T MR scanner (Signa HDx, GE Healthcare,
Milwaukee, Wisconsin) with an 8-channel phased-array head coil. Whole-brain
T1-weighted imaging data were acquired from all participants and were post-processed
using CAT12 (Computational Analysis Tool, run by SPM12) toolbox (http://www.neuro.uni-jena.de/cat/).
In group comparisons, we performed a voxel-wise two-samples t-test to understand the GM differences between
patient and control groups with age and gender as covariates. The difference
was considered significant if cluster-level corrected P < 0.05 (uncorrected P<0.01
and cluster > 200 voxels). In addition, a non-parametric Spearman’s rank
correlation coefficient was calculated to understand associations between GM
volume and duration of coma in CO patients, and statistical significance was
determined as P<0.05.Results and Discussion:
In acute CO patients, GM
volumes were significantly decreased mainly in the frontal and occipital lobes,
as well as in the central GM structures, as shown in Fig. 1A. These regions included
cerebellum, amygdala, hypothalamus, thalamus, insula, anterior and posterior
cingulate, prefrontal cortex, supplementary motor area, somatosensory cortex,
secondary somatosensory cortex, and parietal cortex. However, the GM volumes
were significantly increased in the periaqueductal gray (pain-modulating
center) in CO patients, as shown in Fig. 1B. These findings suggest that GM
changes are mostly in the pain-matrix network and are likely associated with
headache symptoms in CO patients. In addition, the correlation analysis
revealed that GM volumes were significantly negatively correlated with duration
of coma in prefrontal cortex (r=-0.49), posterior cingulate cortex (r=-0.49), insula
(r=-0.46) and amygdala (r=-0.50), suggesting that the duration of coma was
associated with decrease of GM volume in the pain-matrix regions. Therefore, we
concluded that VBM analysis is helpful to understand the headache-associated GM
changes in patients with acute CO intoxication.Acknowledgements
No acknowledgement found.References
1. Weaver LK. Carbon Monoxide Poisoning. New England Journal of Medicine. 2009; 360:
1217-1225.
2. Arngrim N, Schytz
HW, Hauge MK, Ashina M, Olesen J. Carbon monoxide may be an important
molecule in migraine and other headaches. Cephalalgia. 2014; 34: 1169-1180.
3. Rocca MA, Ceccarelli A, Falini A, Colombo B,
Tortorella P, et al. Brain gray matter changes in migraine patients with
T2-visible lesions - A 3-T MRI study. Stroke. 2006; 37: 1765-1770.